For years, many providers stopped using hormone replacement therapy for menopause after a 2002 study showed there was a risk ...

In their review, Bhasin and Snyder (Aug. 7 issue)1 state that most men who receive testosterone preparations are middle-aged or older and have only moderately decreased testosterone ...

November is men’s health month. A time to shed light on men’s health issues and a time to encourage the males in your life to ...

Men don’t escape hormonal changes with age — they just experience them differently. Known as andropause or male menopause, ...

There is no F.D.A.-approved testosterone product for women. Insurance won’t cover it. Many doctors won’t prescribe it. It’s become a cultural phenomenon. Credit... Supported by By Susan Dominus Spend ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological ...

The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs used to treat menopause symptoms, a move many experts say is long overdue.

Women are at much greater risk of dementia than men—as many as two thirds of people in the US with Alzheimer’s disease are women—and likely for a mix of reasons that experts are still parsing out. One ...

Testosterone therapy, broadly referred to as Testosterone Replacement Therapy (TRT), increased approximately 27% from 2008 to 2022 with up to approximately 3% of all US adults having a prescription.

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Accessing Testosterone Replacement Therapy shouldn’t make you ...

In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, ...